Ruby John Anto
Impact in
- Molecular Medicine top 0.2%
- Curcumin's Biomedical Applications
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Natural product bioactivities and synthesis 10
- Genomics, phytochemicals, and oxidative stress 9
- Cell death mechanisms and regulation 6
-
- Curcumin's Biomedical Applications 20
- Co-authors
- Devarajan Karunagaran (7 shared papers)Smitha V. Bava (14 shared papers)Arun Kumar T. Thulasidasan (12 shared papers)Ramadasan Kuttan (4 shared papers)Gopal Srinivas (2 shared papers)Tessy Thomas Maliekal (3 shared papers)Vinod Balachandran (6 shared papers)Girija Kuttan (3 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Frontiers in Oncology (3 papers)RSC Advances (3 papers)Journal of Raman Spectroscopy (3 papers)Medicinal Chemistry Research (3 papers)
- Partner nations
- IndiaUnited StatesIsrael
In The Last Decade
Ruby John Anto
81 papers receiving 3.9k citations
Ruby John Anto's Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Medicine 1.0k
- Toxicology 259
- Biochemistry 236
- Pharmacology 293
- Cancer Research 397
Countries citing papers authored by Ruby John Anto
This map shows the geographic impact of Ruby John Anto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby John Anto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby John Anto more than expected).
Fields of papers citing papers by Ruby John Anto
This network shows the impact of papers produced by Ruby John Anto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby John Anto. The network helps show where Ruby John Anto may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby John Anto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 390 | |
| 2 | 1995 | 271 | |
| 3 | 2002 | 248 | |
| 4 | 2003 | 200 | |
| 5 | 2004 | 197 | |
| 6 | 2003 | 177 | |
| 7 | 2011 | 148 | |
| 8 | 2014 | 132 | |
| 9 | 2012 | 129 | |
| 10 | The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment Hit paper breakdown → | 2023 | 120 |
| 11 | 1996 | 119 | |
| 12 | 2013 | 116 | |
| 13 | 2012 | 108 | |
| 14 | 2022 | 99 | |
| 15 | 2010 | 78 | |
| 16 | 2015 | 70 | |
| 17 | 2005 | 69 | |
| 18 | 2014 | 65 | |
| 19 | 1996 | 62 | |
| 20 | 2012 | 61 |
About Ruby John Anto
Ruby John Anto is a scholar working on Molecular Biology, Molecular Medicine, Organic Chemistry, Cancer Research and Plant Science, having authored 82 papers that have together received 4.1k indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (20 papers), Synthesis and biological activity (10 papers), Natural product bioactivities and synthesis (10 papers), Genomics, phytochemicals, and oxidative stress (9 papers), NF-κB Signaling Pathways (7 papers), Cell death mechanisms and regulation (6 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Bioactive Compounds and Antitumor Agents (5 papers). The work is most often cited by research in Molecular Medicine (1.0k citations), Toxicology (259 citations), Biochemistry (236 citations), Pharmacology (293 citations) and Cancer Research (397 citations). Ruby John Anto has collaborated with scholars based in India, United States and Israel. Frequent co-authors include Devarajan Karunagaran, Smitha V. Bava, Arun Kumar T. Thulasidasan, Ramadasan Kuttan, Gopal Srinivas, Tessy Thomas Maliekal, Vinod Balachandran, Girija Kuttan, Lekshmi R. Nath and Jayesh Antony. Their work appears in journals such as Journal of Biological Chemistry, Frontiers in Oncology, RSC Advances, Journal of Raman Spectroscopy and Medicinal Chemistry Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.